Donate For Public and Patients Store Search

U045 - Integrative Approaches to Common Dermatologic Problems

Saturday, March 2; 4:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Recommend integrative therapies for acne and eczema.
  • Evaluate the role of nutrition and the microbiome in atopic dermatitis, psoriasis, acne, and gluten-sensitive enteropathies.
  • Define functional medicine within the specific context of the dermatologic patient.

Description

This session provides a succinct overview and update on integrative dermatology, with respect to several common dermatologic diagnoses (including acne and atopic dermatitis). Discussion will center around herbs, supplements, dietary considerations, an exploration of functional medicine, and the role of the microbiome in skin health.

Disclosures

  • Baldwin, Hilary E., MD: Allergan, Inc. – A(H); Bayer – SP(NC); Dermira – I(Grants/Research Funding); Galderma Laboratories, L.P. – SP(H); Novan – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – SP(H); Valeant Pharmaceuticals International – SP(H);
  • Goldberg, Matthew S, MD: no financial relationships exist with commercial interests.
  • Jeffries, Michelle L., DO: no financial relationships exist with commercial interests.
  • Lio, Peter A., MD: AbbVie – C(Fees), I(Grants/Research Funding); Altus Labs – A(SO); Amyris, Inc. – C(Fees); AOBiome, LLC – I(Grants/Research Funding); Arbonne – A(H); Burt's Bees – C(Fees); Dermavant Sciences – A(H); Dermira – C(Fees); DermTap, Inc. – A(SO); DermVeda – A(SO); Eli Lilly and Company – C(Fees); Exeltis – C(Fees); Franklin BioScience – C(SO); gpower, inc. – A(H); IntraDerm Pharmaceuticals – A(H); Johnson & Johnson Consumer Products Company – A(H); Kiniksa Pharmaceuticals, Ltd. – C(H); L'Oreal USA Inc. – C(H); La Fondation pour la Dermatite Atopique (Foundation for Atopic Dermatitis – I(Grants/Research Funding); La Roche-Posay Laboratorie Pharmaceutique – SP(H); LearnHealth/LearnSkin – SH(SO); LEO Laboratories Ltd (LEO Pharma) – C(Fees); Medable – SH(SO); Menlo Therapeutics – A(H); Micreos Human Health B.V. – A(SO); Modernizing Medicine – A(NC), SH(SO); National Eczema Association – A(NC); Odeza LLC – C(SO); Pfizer Inc. – SP(H); Pierre Fabre Dermatologie – SP(H); Realm Therapeutics – A(H); Regeneron – A(Fees), I(Grants/Research Funding), SP(Fees); Sanofi US Services – A(H); Syncere Skin Systems – A(SO); Theraplex – C(Fees), O(IP); TopMD – C(Fees); UCB – A(H); Unilever – C(Fees); Verrica Pharmaceuticals Inc – A(H);
  • Rupani, Reena N., MD: Nutrafol – SP(H);
Schedule
Saturday, March 2
4:30 PM
Dr. Rupani / INTRODUCTION
4:40 PM
Dr. Lio / Super-organism: The role of the microbiome in skin
4:50 PM
Dr. Jeffries / Functional Medicine in Dermatology
5:00 PM
Dr. Baldwin / Integrative Care of Acne
5:10 PM
Dr. Goldberg / Update on Diet and Dermatology
5:20 PM
All faculty / Q&A
Event Details
  • Date
    Saturday, March 2
  • Time
    4:30 PM - 5:30 PM
  • Location
    Room 146B
  • CME Credits
    1.00
  • Type
Directors/Co-Directors
  • Reena N. Rupani, MD, FAAD
Speakers
  • Hilary E. Baldwin, MD, FAAD
  • Matthew S Goldberg, MD, FAAD
  • Michelle L. Jeffries, DO, FAAD
  • Peter A. Lio, MD, FAAD - Handout